Cargando…

Effect of SARS-CoV-2 Infection on Anti-HLA Antibodies and De Novo DSA Incidence in Lung Transplant Recipients

PURPOSE: The SARS-CoV-2 pandemic has brought many challenges into the field of transplantation. The infection itself leads to a broad activation of B-lymphocytes, which in combination with reduced immunosuppression and systemic pro-inflammatory state may possibly lead to an alloimmune response. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zajacova, A., Dvorackova, E., Vyskocilova, K., Casas-Mendez, L., Kotowski, T., Valentova-Bartakova, L., Fila, L., Lischke, R., Havlin, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	(353)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988647/ http://dx.doi.org/10.1016/j.healun.2022.01.374

Ejemplares similares

Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model
por: Dvořáčková, Eliška, et al.
Publicado: (2023)

Continued Smoking in Lung Transplant Patients: A Cross Sectional Survey
por: ZMEŠKAL, Miroslav, et al.
Publicado: (2015)

Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients
por: Dvořáčková, Eliška, et al.
Publicado: (2022)

Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients
por: Havlin, Jan, et al.
Publicado: (2021)

Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study
por: Matignon, Marie, et al.
Publicado: (2017)

Differential Treatment Effects for Renal Transplant Recipients With DSA-Positive or DSA-Negative Antibody-Mediated Rejection
por: Koslik, Marius Andreas, et al.
Publicado: (2022)

The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA
por: Jucaud, Vadim
Publicado: (2017)

Antibody-removal therapies for de novo DSA in pediatric intestinal recipients: Why, when, and how? A single-center experience
por: Lasa-Lázaro, María, et al.
Publicado: (2023)

Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014
por: Girerd, S., et al.
Publicado: (2018)

Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients
por: de Sousa, Marcos Vinicius, et al.
Publicado: (2018)

The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant Recipients
por: Modaresi Esfeh, J., et al.
Publicado: (2012)

Posttransplant de novo DSA and NDSA affect GvHD, OS, and DFS after haplo-HSCT in patients without pre-existing HLA antibodies of hematological malignancies
por: Wang, Lan, et al.
Publicado: (2022)

Donor-derived Cell-free DNA Complements De Novo Class II DSA in Detecting Late Alloimmune Injury Post Kidney Transplantation
por: Butiu, Maria, et al.
Publicado: (2022)

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients
por: O'Leary, Jacqueline G., et al.
Publicado: (2016)

P1322: EFFECTS OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES (DSA) FOR PRIMARY GRAFT FAILURE OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA MAJOR
por: Liao, Jianyun, et al.
Publicado: (2023)

Intensity of de novo DSA detected by Immucor Lifecodes assay and C3d fixing antibodies are not predictive of subclinical ABMR after Kidney Transplantation
por: Bertrand, Dominique, et al.
Publicado: (2021)

Low Incidence of Acute Antibody-Mediated Rejection after HLA Desensitization in Living Donor Kidney Transplant Recipients
por: Fernández Rivera, Constantino, et al.
Publicado: (2022)

DSA1.2 - Software Release Plan
Publicado: (July)

DSA2.1 - Quality Assurance Plan
Publicado: (June)

Value of DSA in the Diagnostic Workup of Pulsatile Tinnitus
por: Deuschl, Cornelius, et al.
Publicado: (2015)

Pre-formed DSA and kidney allograft outcomes
por: Yeung, Melissa Y.
Publicado: (2020)

Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020)

Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
por: Park, Ji Eun, et al.
Publicado: (2018)

Correlation of HLA-DP/DQ polymorphisms with transplant etiologies and prognosis in liver transplant recipients
por: Li, Yi, et al.
Publicado: (2017)

Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant Recipients
por: Hernández, Domingo, et al.
Publicado: (2021)

Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study
por: Sakamoto, Shintaro, et al.
Publicado: (2020)

Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients
por: Toyoda, Mieko, et al.
Publicado: (2017)

De Novo Cytomegalovirus Colitis in a Donor-Seronegative/Recipient-Seronegative Kidney Transplant Recipient
por: Sulaiman, Zoheb I, et al.
Publicado: (2023)

Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients
por: Lee, Hyeyoung, et al.
Publicado: (2018)

Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2022)

Vaccination Against SARS-CoV-2 in Lung Transplant Recipients: Immunogenicity, Efficacy and Safety
por: Svorcova, Monika, et al.
Publicado: (2022)

DSA2.4 - Continuous Integration and Certification Testbeds
Publicado: (July)

DSA1.1 - Software Maintenance and Support Plan
Publicado: (May )

DSA2.2.1 - QA Tools Documentation
Publicado: (June)

DSA2.2.2 - QA Tools Documentation
por: Members of EMI collaboration
Publicado: (Febr)

DSA2.2.3 - QA Tools Documentation
por: Members of EMI collaboration
Publicado: (Febr)

DSA2.3.1 - Periodic QA Reports
Publicado: (July)

DSA2.3.2 - Periodic QA Reports
por: Members of EMI collaboration
Publicado: (Apri)

DSA2.3.3 - Periodic QA Reports
por: Members of EMI collaboration
Publicado: (Apri)

Post-pancreaticoduodenectomy hemorrhage: DSA diagnosis and endovascular treatment
por: Zhou, Tan-Yang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1qjd1ksfvrh9ik0go2ri8lflc4